Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1I9B

X-RAY STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP)

Summary for 1I9B
Entry DOI10.2210/pdb1i9b/pdb
DescriptorACETYLCHOLINE BINDING PROTEIN, CALCIUM ION, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, ... (4 entities in total)
Functional Keywordspentamer, igg fold, ligand binding protein
Biological sourceLymnaea stagnalis (great pond snail)
Cellular locationSecreted: P58154
Total number of polymer chains5
Total formula weight124953.86
Authors
Brejc, K.,van Dijk, W.J.,Klaassen, R.,Schuurmans, M.,van der Oost, J.,Smit, A.B.,Sixma, T.K. (deposition date: 2001-03-18, release date: 2001-05-16, Last modification date: 2018-03-07)
Primary citationBrejc, K.,van Dijk, W.J.,Klaassen, R.V.,Schuurmans, M.,van Der Oost, J.,Smit, A.B.,Sixma, T.K.
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
Nature, 411:269-276, 2001
Cited by
PubMed Abstract: Pentameric ligand gated ion-channels, or Cys-loop receptors, mediate rapid chemical transmission of signals. This superfamily of allosteric transmembrane proteins includes the nicotinic acetylcholine (nAChR), serotonin 5-HT3, gamma-aminobutyric-acid (GABAA and GABAC) and glycine receptors. Biochemical and electrophysiological information on the prototypic nAChRs is abundant but structural data at atomic resolution have been missing. Here we present the crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homologue of the amino-terminal ligand-binding domain of an nAChR alpha-subunit. In the AChBP homopentamer, the protomers have an immunoglobulin-like topology. Ligand-binding sites are located at each of five subunit interfaces and contain residues contributed by biochemically determined 'loops' A to F. The subunit interfaces are highly variable within the ion-channel family, whereas the conserved residues stabilize the protomer fold. This AChBP structure is relevant for the development of drugs against, for example, Alzheimer's disease and nicotine addiction.
PubMed: 11357122
DOI: 10.1038/35077011
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon